Disease-A-Month
Volume 52, Issue 11 , Pages 450-458 , November 2006

Laboratory Diagnosis of Tuberculosis in Primary Care

References 

  1. Centers for Disease Control and Prevention 2004 Surveillance Data, Reported Tuberculosis. www.cdc.gov/nchtsp/tb/surv2004/pdf/.
  2. Centers for Disease Control and Prevention. Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR. 2005;54:1–81No. RR-12
  3. Heifets L, Desmond E. Clinical Mycobacteriology (Tuberculosis) Laboratory: Services and Methods. In:  Cole ST,  Eisenach L,  McMurray DN, et al. editor. Tuberculosis and the Tubercle Bacillus. Washington DC: ASM Press; 2005;p. 49–60
  4. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000;161(4 Pt. 1):1376–1395Apr
  5. Lee CH, Kim WJ, Yoo CG, et al. Response to empirical anti-tuberculosis treatment in patients with sputum smear-negative presumptive pulmonary tuberculosis. Respiration. 2005;72(4):369–374
  6. Behr MA, Warren SA, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet. 1999;353(9151):444–449
  7. Murray PR, Rosenthal KS, Kobayashi GS, et al. Mycobacterium. In:  Murray PR,  Rosenthal KS,  Kobayashi GS, et al. editor. Medical Microbiology. 4th ed.. St. Louis, MO: Mosby, Inc; 2002;p. 366–377
  8. Moore DF, Guzman JA, Mikhail LT. Reduction in turnaround time for laboratory diagnosis of pulmonary tuberculosis by routine use of a nucleic acid amplification test. Diagn Microbiol Infect Dis. 2005;52(3):247–254
  9. Mixides G, Shende V, Teeter LD, et al. Number of negative acid-fast smears needed to adequately assess infectivity of patients with pulmonary tuberculosis. Chest. 2005;128(1):108–115
  10. Finch D, Beaty CD. The utility of a single sputum specimen in the diagnosis of tuberculosis (Comparison between HIV-infected and non-HIV-infected patients). Chest. 1997;111(5):1174–1179
  11. Al Zahrani K, Al Jahdali H, Poirier L, et al. Yield of smear, culture and amplification tests from repeated sputum induction for the diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis. 2001;5(9):855–860
  12. Saglam L, Akgun M, Aktas E. Usefulness of induced sputum and fibreoptic bronchoscopy specimens in the diagnosis of pulmonary tuberculosis. J Int Med Res. 2005;33(2):260–265
  13. Alisjahbana B, vanCrevel R, Danusantoso H, et al. Better patient instruction for sputum sampling can improve microscopic tuberculosis diagnosis. Int J Tuberc Lung Dis. 2005;9(7):814–817Jul
  14. Hanna BA. Laboratory Diagnosis. In:  Rom WN,  Garay SM editor. Tuberculosis. 2nd ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2004;p. 163–176
  15. Strumpf IJ, Tsang AY, Sayre JW. Re-evaluation of sputum staining for the diagnosis of pulmonary tuberculosis. Am Rev Respir Dis. 1979;119(4):599–602
  16. Cheng AG, Chang A, Farwell DG, et al. Auramine orange stain with fluorescence microscopy is a rapid and sensitive technique for the detection of cervical lymphadenitis due to mycobacterial infection using fine needle aspiration cytology: a case series. Otolaryngol Head Neck Surg. 2005;133(3):381–385
  17. Polesky A, Grove W, Bhatia G. Peripheral tuberculous lymphadenitis: epidemiology, diagnosis, treatment, and outcome. Medicine (Baltimore). 2005;84(6):350–362
  18. Jogirdan J, Zagzag D. Pathology and insights into pathogenesis of tuberculosis. In:  Rom WN,  Garay SM editor. Tuberculosis. 2nd ed.. Philadelphia (PA): Lippincott Williams & Wilkins; 2004;p. 323–344
  19. Reuter H, Burgess LJ, Schneider J, et al. The role of histopathology in establishing the diagnosis of tuberculous pericardial effusions in the presence of HIV. Histopathology. 2006;48(3):295–302
  20. Plorde JJ, Mycobacteria . In:  Ryan KJ editors. Sherris Medical Microbiology: An Introduction to Infectious Diseases. 3rd ed.. Stamford, CT: Appleton & Lange; 1994;p. 401–415
  21. Dooley KE, Golub J, Goes FS, et al. Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis. Clin Infect Dis. 2002;34(12):1607–1612
  22. Yoon YS, Lee HJ, Yoon HI, et al. Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia. Int J Tuberc Lung Dis. 2005;9(11):1215–1219
  23. Chakravorty S, Tyagi JS. Novel multipurpose methodology for detection of mycobacteria in pulmonary and extrapulmonary specimens by smear microscopy, culture, and PCR. J Clin Microbiol. 2005;43(6):2697–2702
  24. Chakravorty S, Sen MK, Tyagi JS. Diagnosis of extrapulmonary tuberculosis by smear, culture, and PCR using universal sample processing technology. J Clin Microbiol. 2005;43(9):4357–4362
  25. Kamholz SL. Pleural tuberculosis. In:  Rom WN,  Garay SM editor. Tuberculosis. 2nd ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2004;p. 497–507
  26. Cheng VC, Yew WW, Yuen KY. Molecular diagnostics in tuberculosis. Eur J Clin Microbiol Infect Dis. 2005;24(11):711–720
  27. Centers for Disease Control and Prevention. Notice to Readers: Update: nucleic acid amplification tests for tuberculosis. MMWR. 2000;49(26):593–594Jul 07
  28. Laifer G, Widmer AF, Frei R, et al. Polymerase chain reaction for Mycobacterium tuberculosis: impact on clinical management of refugees with pulmonary infiltrates. Chest. 2004;125(3):981–986
  29. Greco S, Girardi E, Masciangelo R, et al. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int J Tuberc Lung Dis. 2003;7(8):777–786
  30. Hiraki A, Aoe K, Eda R, et al. Comparison of six biological markers for the diagnosis of tuberculous pleuritis. Chest. 2004;125(3):987–989
  31. Gaga M, Papamichalis G, Bakakos P, et al. Tuberculous effusion: ADA activity correlates with CD4+ cell numbers in the fluid and the pleura. Respiration. 2005;72(2):160–165
  32. Lima DM, Colares JK, da Fonseca BA. Combined use of the polymerase chain reaction and detection of adenosine deaminase activity on pleural fluid improves the rate of diagnosis of pleural tuberculosis. Chest. 2003;124(3):909–914
  33. Villegas MV, Labrada LA, Saravia NG. Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis. Chest. 2000;1185:1355–1364
  34. Mazurek GH, Jereb J, Lobue P, et al. Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC) (Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States). MMWR Recomm Rep. 2005;54(RR-15):49–55
  35. Porsa E, Cheng L, Seale MM, et al. Comparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population. Clin Vaccine Immunol. 2006;13(1):53–58
  36. Dewan PK, Grinsdale J, Liska S, et al. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis. 2006;6:47
  37. Brock I, Ruhwald M, Lundgren B, et al. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon gamma test. Respir Res. 2006;7(1):56
  38. Demissie A, Leyten EM, Abebe M, et al. VACSEL Study Group Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin Vaccine Immunol. 2006;13(2):179–186
  39. Ferrara G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med. 2005;172(5):631–635
  40. Meier T, Eulenbruch HP, Wrighton-Smith P, et al. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis. 2005;24(8):529–536
  41. Iseman MD. A Clinician’s Guide to Tuberculosis. Philadelphia, PA: Lippincott Williams & Wilkins; 2000;
  42. Garay S. Pulmonary Tuberculosis. In:  Rom WN,  Garay SM editor. Tuberculosis. 2nd ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2004;p. 345–394
  43. Baker SK, Glassroth J. Miliary Tuberculosis. In:  Rom WN,  Garay SM editor. Tuberculosis. 2nd ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2004;p. 427–444
  44. Attallah AM, Osman S, Saad A, et al. Application of a circulating antigen detection immunoassay for laboratory diagnosis of extra-pulmonary and pulmonary tuberculosis. Clin Chim Acta. 2005;356(1-2):58–66
  45. Tong M, Jacobi CE, van de Rijke FM, et al. A multiplexed and miniaturized serological tuberculosis assay identifies antigens that discriminate maximally between TB and non-TB sera. J Immunol Methods. 2005;301(1-2):154–163

PII: S0011-5029(06)00094-0

doi: 10.1016/j.disamonth.2006.09.011

Disease-A-Month
Volume 52, Issue 11 , Pages 450-458 , November 2006

Article Tools

* Image Usage & Resolution